Talasaz AmirAli 4
4 · Guardant Health, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Guardant Health CEO Talasaz AmirAli Sells 210,000 Shares
What Happened
Talasaz AmirAli, CEO of Guardant Health (GH), sold a total of 210,000 shares in multiple open-market transactions on May 20, 2026. The sales were executed in 12 tranches at prices reported between about $100.95 and $112.76 (footnotes indicate some trades in the full range up to $112.93), generating aggregate proceeds of approximately $23.08 million. This filing reports sales (transaction code S) rather than purchases or option exercises.
Key Details
- Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (filed within the typical 2-business-day reporting window).
- Total shares sold: 210,000; Total proceeds: ~$23,076,690.
- Prices: individual tranches reported at weighted average prices from $100.95 up to $112.76; footnotes disclose more granular ranges across the tranches (roughly $102.29–$112.93 for grouped lots).
- Number of reported tranches: 12 separate sale entries.
- Shares owned after transaction: Not specified in the provided data.
- Notable footnotes: Several entries use weighted-average prices and state the Reporting Person will provide a breakdown of shares sold at each specific price on request. No 10b5‑1 plan, tax‑withholding, or gift language was disclosed in the summary provided.
Context
This was an open-market sale (liquidity event) by the CEO. Sales by insiders are common and can reflect personal liquidity needs or diversification; they are not, by themselves, definitive signals about the company’s outlook. Retail investors often watch insider purchases more closely as potential positive signals, while large sales should be noted but interpreted in context (holding levels, prior disclosures, and company fundamentals).
Insider Transaction Report
Form 4
Talasaz AmirAli
DirectorCo-Chief Executive Officer
Transactions
- Sale
Common Stock
2026-05-20$100.95/sh−200$20,190→ 2,096,304 total(indirect: By Trust) - Sale
Common Stock
[F1]2026-05-20$102.57/sh−900$92,313→ 2,095,404 total(indirect: By Trust) - Sale
Common Stock
[F2]2026-05-20$103.82/sh−1,366$141,815→ 2,094,038 total(indirect: By Trust) - Sale
Common Stock
[F3]2026-05-20$105.01/sh−11,919$1,251,589→ 2,082,119 total(indirect: By Trust) - Sale
Common Stock
[F4]2026-05-20$105.88/sh−1,200$127,050→ 2,080,919 total(indirect: By Trust) - Sale
Common Stock
[F5]2026-05-20$106.99/sh−21,171$2,265,126→ 2,059,748 total(indirect: By Trust) - Sale
Common Stock
[F6]2026-05-20$108.11/sh−33,069$3,574,961→ 2,026,679 total(indirect: By Trust) - Sale
Common Stock
[F7]2026-05-20$108.97/sh−9,852$1,073,547→ 2,016,827 total(indirect: By Trust) - Sale
Common Stock
[F8]2026-05-20$110.10/sh−28,908$3,182,652→ 1,987,919 total(indirect: By Trust) - Sale
Common Stock
[F9]2026-05-20$111.14/sh−37,163$4,130,470→ 1,950,756 total(indirect: By Trust) - Sale
Common Stock
[F10]2026-05-20$112.02/sh−37,900$4,245,547→ 1,912,856 total(indirect: By Trust) - Sale
Common Stock
[F11]2026-05-20$112.76/sh−26,352$2,971,430→ 1,886,504 total(indirect: By Trust)
Footnotes (11)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.29 to $103.06. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F10]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.73 to $112.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F11]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.74 to $112.93. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.40 to $104.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.400 to $105.39. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.49 to $106.42. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.57 to $107.52. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.59 to $108.57. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $108.59 to $109.56. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F8]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.58. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F9]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.72 to $111.71. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Signature
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz|2026-05-22